Optolexia secures SEK 50M for launching its services in the United States.
Optolexia, a Stockholm, Sweden-based medical company offering screentests for dyslexia in children, announced an investment round of SEK 50M ($5.61M). The backers include Pomona Group and Gabriel Urwitz and the money will be used for expanding the company's operations in USA.
Optolexia, founded in 2015 by Gustaf Öqvist Seimyr, Mattias Nilsson Benfatto and Fredrik Wetterhall (CEO), provides a solution intended for primary schools, and which offers early, fast, and accurate identification of children at risk of dyslexia and safely rules out those not at risk. Specifically, the company has developed a camera that records eye movements during reading, which is then analyzed using artificial intelligence.
Prior to this transaction, Optolexia raised about $3M in external funding.